Figure 3
Figure 3. HDAC inhibitors differ in their ability to suppress IFNα induction of PML. Western blot analysis of PML protein levels in HeLa cells (A-C) or HSFs (D) simultaneously treated for 24 hours with IFNα and one of the following HDAC inhibitors: BUT, VA, SAHA, or MS-275. The final concentrations of the inhibitors are indicated. Cell protein lysates (25 μg total protein) were loaded on 8% SDS gels (actin band of Ponceau S–stained membrane or GAPDH signal is shown to demonstrate equal loading). (E) Real-time RT-PCR quantification of HDAC inhibitors' suppression of IFNα-induced PML mRNA. HeLa cells were treated with 1000 U/mL IFNα alone or simultaneously with a particular HDAC inhibitor for 8 hours. PML mRNA levels were normalized to GAPDH. Statistically significant differences compared with the IFNα-treated cells are indicated by ***P < .001, **P < .005, or *P < .05; 3 independent experiments were evaluated. Error bars represent standard error.

HDAC inhibitors differ in their ability to suppress IFNα induction of PML. Western blot analysis of PML protein levels in HeLa cells (A-C) or HSFs (D) simultaneously treated for 24 hours with IFNα and one of the following HDAC inhibitors: BUT, VA, SAHA, or MS-275. The final concentrations of the inhibitors are indicated. Cell protein lysates (25 μg total protein) were loaded on 8% SDS gels (actin band of Ponceau S–stained membrane or GAPDH signal is shown to demonstrate equal loading). (E) Real-time RT-PCR quantification of HDAC inhibitors' suppression of IFNα-induced PML mRNA. HeLa cells were treated with 1000 U/mL IFNα alone or simultaneously with a particular HDAC inhibitor for 8 hours. PML mRNA levels were normalized to GAPDH. Statistically significant differences compared with the IFNα-treated cells are indicated by ***P < .001, **P < .005, or *P < .05; 3 independent experiments were evaluated. Error bars represent standard error.

Close Modal

or Create an Account

Close Modal
Close Modal